RECOGNITION AND ASSESSMENT

Symptoms and signs

  • Nausea
  • Cramps
  • Confusion, seizures, varied CNS manifestations
  • Unless serum sodium (Na+) falling rapidly, concentrations in range 125–135 mmol/L are usually asymptomatic
  • Those of underlying cause

Clinical assessment

  • Assess state of hydration: BP, pulse, skin turgor, monitor urine output

Investigations

  • Take sample from arm without a drip
  • FBC and U&E (eosinophilia, hyperkalaemia, or hypercalcaemia suggest hypoadrenalism)
  • Glucose
  • Osmolality (urine plus serum), urine Na+, TFT

MANAGEMENT

  • Treat the underlying cause. For guidance follow Flowchart. Further information available from clinical biochemistry or from renal or endocrine teams

Sodium levels

  • Monitor at least daily
  • If a patient has a high urine output and/or very low Na <115 mmol/L, monitor electrolytes 4-hrly initially to avoid sudden rises in serum Na+
  • Rapid changes in sodium are more dangerous than LOW Na+ ITSELF, even when the change is corrective
  • Hypertonic saline is almost never justified, carries a significant risk, should be given only with consultant approval and requires monitoring in a high dependency area
  • Failure to correct, or recurrence of hyponatraemia merits referral to the team appropriate to the underlying cause (e.g. renal, endocrine, psychiatric)
  • Review drug treatment before discharge
Management flowchart tool
test-flowchart-1